Citius Pharmaceuticals, Inc. price (CTXR)

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on September 9, 2010 and is headquartered in Cranford, NJ.